Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001539497-23-000006
Filing Date
2023-01-13
Accepted
2023-01-13 08:02:14
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A n3315_x2-sc13ga.htm SC 13G/A 44726
  Complete submission text file 0001539497-23-000006.txt   45927
Mailing Address 2110 NARCISSUS CT VENICE CA 90291
Business Address 2110 NARCISSUS CT VENICE CA 90291 8184226172
Pasithea Therapeutics Corp. (Subject) CIK: 0001841330 (see all company filings)

EIN.: 851591963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92867 | Film No.: 23527304
SIC: 2834 Pharmaceutical Preparations

Mailing Address 411 RIDGE ROAD ORANGE, CONNECTICUT 06477 CT 06477
Business Address
Khire Uday (Filed by) CIK: 0001951240 (see all company filings)

Type: SC 13G/A